Price graph
Price vs Rates, Inflation & Volume (long-term)
Quality Scorecard Growth
Growth-stage checklist (proxy metrics from yfinance). 12 of 12 criteria scored. Not financial advice.
Buy-Now Score
Comparative rank: 40% Quality + 30% Trajectory + 30% Valuation — higher = better buy now. Not financial advice.
Valuation
DCF: 9% start growth → 2.5%, 11.3% discount (band $338.29–$535.81). Analyst: 15 analysts. MarketGist fair = 80% analyst + 20% DCF. Not financial advice.
Key Trends (6-yr)
Company Overview
Basic Information
Company Details
Business Description
ASML Holding N.V. provides lithography solutions for the development, production, marketing, sales, upgrading, and servicing of advanced semiconductor equipment systems. The company offers lithography, metrology, and inspection systems. It also provides extreme ultraviolet lithography systems; and deep ultraviolet lithography systems comprising immersion and dry lithography systems solutions to manufacture various range of semiconductor nodes and technologies. In addition, the company offers metrology and inspection systems, including YieldStar optical metrology systems, a diffraction-based wafer metrology platform to assess the quality of patterns on the wafers; and HMI electron beam solutions to locate and analyze individual chip defects. Further, it provides computational lithography solutions, and lithography systems and control software solutions; and refurbishes and upgrades lithography systems, as well as offers customer support and related services. Additionally, the company offers hardware, software, and services to chipmakers to produce the patterns of integrated circuits. It operates in Japan, South Korea, Singapore, Taiwan, China, rest of Asia, the Netherlands, rest of Europe, the Middle East, Africa, and the United States. The company was formerly known as ASM Lithography Holding N.V. and changed its name to ASML Holding N.V. in 2001. ASML Holding N.V. was founded in 1984 and is headquartered in Veldhoven, the Netherlands.
Key Metrics
Price & Valuation
Profitability
Financial Health
Trading & Analyst Info
52-Week Range
Analyst Recommendations
Fundamental Trends
Quarterly Verdict
Heuristic from the Quality Scorecard + quarter-over-quarter trends. Not financial advice.
Financial Statements
Income Statement (Annual)
| Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | $0.00 | $0.00 | $0.00 | $0.00 | N/A |
| Tax Rate For Calcs | $0.18 | $0.19 | $0.16 | $0.15 | N/A |
| Normalized EBITDA | $12.55B | $10.12B | $9.98B | $7.10B | N/A |
| Total Unusual Items | N/A | N/A | N/A | N/A | $213.70M |
| Total Unusual Items Excluding Goodwill | N/A | N/A | N/A | N/A | $213.70M |
| Net Income From Continuing Operation Net Minority Interest | $9.61B | $7.57B | $7.84B | $5.62B | N/A |
| Reconciled Cost Of Revenue | $15.41B | $13.77B | $13.42B | $10.47B | N/A |
| EBITDA | $12.55B | $10.12B | $9.98B | $7.10B | N/A |
| EBIT | $11.52B | $9.21B | $9.24B | $6.52B | N/A |
| Net Interest Income | $104.70M | $19.80M | $41.20M | $-44.60M | N/A |
| Interest Expense | $118.30M | $162.60M | $152.70M | $60.80M | N/A |
| Interest Income | $223.00M | $182.40M | $193.90M | $16.20M | N/A |
| Normalized Income | $9.61B | $7.57B | $7.84B | $5.62B | N/A |
| Net Income From Continuing And Discontinued Operation | $9.61B | $7.57B | $7.84B | $5.62B | N/A |
| Total Expenses | $21.37B | $19.24B | $18.52B | $14.67B | N/A |
Showing 15 of 44 rows
Balance Sheet (Annual)
| Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Treasury Shares Number | $2.73M | $546.97K | $6.16M | $8.55M | N/A |
| Ordinary Shares Number | $385.42M | $393.28M | $393.42M | $394.59M | N/A |
| Share Issued | $388.15M | $393.83M | $399.58M | $403.14M | N/A |
| Total Debt | $4.39B | $4.69B | $4.63B | $4.26B | N/A |
| Tangible Book Value | $14.48B | $13.27B | $8.12B | $3.41B | N/A |
| Invested Capital | $24.00B | $23.16B | $18.08B | $13.07B | N/A |
| Working Capital | $6.35B | $10.69B | $8.12B | $5.08B | N/A |
| Net Tangible Assets | $14.48B | $13.27B | $8.12B | $3.41B | N/A |
| Common Stock Equity | $19.61B | $18.48B | $13.45B | $8.81B | N/A |
| Total Capitalization | $22.32B | $22.15B | $18.08B | $12.32B | N/A |
| Total Equity Gross Minority Interest | $19.61B | $18.48B | $13.45B | $8.81B | N/A |
| Stockholders Equity | $19.61B | $18.48B | $13.45B | $8.81B | N/A |
| Gains Losses Not Affecting Retained Earnings | $135.80M | $454.10M | $345.00M | $428.30M | N/A |
| Other Equity Adjustments | $135.80M | $454.10M | $345.00M | $428.30M | N/A |
| Treasury Stock | $2.25B | $476.00M | $3.31B | $4.64B | N/A |
Showing 15 of 82 rows
Cash Flow Statement (Annual)
| Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $11.03B | $9.08B | $3.25B | $7.17B | N/A |
| Repurchase Of Capital Stock | $-5.95B | $-500.00M | $-1.00B | $-4.64B | N/A |
| Repayment Of Debt | $-1.07B | $-25.70M | $-752.80M | $-516.20M | N/A |
| Issuance Of Debt | $754.20M | $22.50M | $997.80M | $495.60M | N/A |
| Issuance Of Capital Stock | $142.30M | $124.00M | $99.40M | $81.80M | N/A |
| Capital Expenditure | $-1.63B | $-2.08B | $-2.20B | $-1.32B | N/A |
| Interest Paid Supplemental Data | $114.50M | $160.00M | $137.80M | $82.20M | N/A |
| Income Tax Paid Supplemental Data | $1.62B | $1.10B | $2.57B | $1.73B | N/A |
| End Cash Position | $12.92B | $12.74B | $7.00B | $7.27B | N/A |
| Beginning Cash Position | $12.74B | $7.00B | $7.27B | $6.95B | N/A |
| Effect Of Exchange Rate Changes | $-30.10M | $6.40M | $-13.80M | $-3.10M | N/A |
| Changes In Cash | $210.20M | $5.72B | $-249.80M | $319.60M | N/A |
| Financing Cash Flow | $-8.67B | $-2.83B | $-3.00B | $-7.14B | N/A |
| Cash Flow From Continuing Financing Activities | $-8.67B | $-2.83B | $-3.00B | $-7.14B | N/A |
| Cash Dividends Paid | $-2.55B | $-2.45B | $-2.35B | $-2.56B | N/A |
Showing 15 of 57 rows